Abstract:BackgroundFibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT.MethodsA549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA.ResultsThe data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes.ConclusionOur study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon.

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

Transforming Growth Factor-Beta 1 Induces Epithelial-To-Mesenchymal Transition In Human Lung Cancer Cells Via Pi3k/Akt And Mek/Erk1/2 Signaling Pathways

Transforming Growth Factor-Β1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Epithelial-to-mesenchymal Transition

Research of TGF-beta1 Inducing Lung Adencarcinoma PC9 Cells to Mesenchymal Cells Transition

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer.

Transforming Growth Factor-Β1 Regulates Epithelial-Mesenchymal Transition in Association with Cancer Stem-Like Cells in a Breast Cancer Cell Line.

Transforming Growth Factor-Β1 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis.

Alteration of mitochondrial synthesis and function in epithelial-mesenchymal transition by TGF-β1

Roles of p38 MAPK and JNK in TGF-β1-induced alveolar epithelial to mesenchymal transition

TGF-β1 Induces Epithelial-to-mesenchymal Transition Via Inhibiting Mitochondrial Functions in A549 Cells.

TGF-β1/miR-30d-5p axis regulating the expression of EMT key factors to induce apoptosis of lung cancer cells

TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases Via Downregulation of Non Muscle Myosin II-A Through JNK/P38/PI3K Pathway in Lung Cancer.

Roles of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to mesenchymal transition.

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC

Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

bFGF Induced Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cell Line A549

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

JAK/STAT3 Signaling is Required for TGF-β-induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer